Article Text

Download PDFPDF
Percutaneous renal denervation: new treatment option for resistant hypertension and more?

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors SE, CU, MB and FM have substantially contributed to the interpretation of data and drafting of the article. All authors have approved the final version of the manuscript to be published.

  • Competing interests In compliance with EBAC/EACCME guidelines, all authors participating in Education in Heart have disclosed potential conflicts of interest that might cause a bias in the article. The institution has received scientific support from Medtronic/Ardian. MB and FM were investigators of the Symplicity HTN1 and HTN 2 trials. CU, MB and FM have received speaker honorarium and consultancy from Medtronic/Ardian. CU, MB and FM are supported by Deutsche Forschungsgemeinschaft (KFO 196). SE and FM is supported by Deutsche Hochdruckliga.

  • Provenance and peer review Commissioned; internally peer reviewed.